{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:23:08Z","timestamp":1791469388533,"version":"4.3.4"},"reference-count":93,"publisher":"Impact Journals, LLC","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,5,22]]},"DOI":"10.18632\/oncotarget.25432","type":"journal-article","created":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T06:35:34Z","timestamp":1526711734000},"page":"25661-25680","source":"Crossref","is-referenced-by-count":17,"title":["Altered membrane rigidity via enhanced endogenous cholesterol synthesis drives cancer cell resistance to destruxins"],"prefix":"10.18632","volume":"9","author":[{"given":"Daniela","family":"Heilos","sequence":"first","affiliation":[{"name":"Institute of Cancer Research, Department of Internal Medicine I, Medical University of Vienna, Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria"},{"name":"Department of Pharmacology and Toxicology, University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"R\u00f6hrl","sequence":"additional","affiliation":[{"name":"Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Pirker","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Internal Medicine I, Medical University of Vienna, Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Englinger","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Internal Medicine I, Medical University of Vienna, Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Baier","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Internal Medicine I, Medical University of Vienna, Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria"},{"name":"Decentralized Biomedical Facilities of the Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mohr","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Internal Medicine I, Medical University of Vienna, Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Schwaiger","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid Muhammad","family":"Iqbal","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushilla","family":"van Schoonhoven","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Internal Medicine I, Medical University of Vienna, Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristaps","family":"Klavins","sequence":"additional","affiliation":[{"name":"BIOCRATES Life Sciences AG, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Eberhart","sequence":"additional","affiliation":[{"name":"Center for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Windberger","sequence":"additional","affiliation":[{"name":"Decentralized Biomedical Facilities of the Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Taibon","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy, Pharmacognosy and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Sturm","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy, Pharmacognosy and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Stuppner","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy, Pharmacognosy and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunda","family":"Koellensperger","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria"},{"name":"Vienna Metabolomics Center, University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Dornetshuber-Fleiss","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Internal Medicine I, Medical University of Vienna, Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria"},{"name":"Department of Pharmacology and Toxicology, University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"J\u00e4ger","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Division of Clinical Pharmacy and Diagnostics, University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Lemmens-Gruber","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Berger","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Internal Medicine I, Medical University of Vienna, Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"1","unstructured":"WHO. http:\/\/wwwwhoint\/cancer\/en\/. Accessed 17 Aug 2017."},{"key":"2","first-page":"59","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Bray","year":"2015","journal-title":"Int J Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Jemal","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1634\/theoncologist.1-3-180","article-title":"Anticancer drug development: the way forward","volume":"1","author":"Connors","year":"1996","journal-title":"Oncologist"},{"key":"5","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jamaoto.2014.1570","article-title":"Unintended consequences of expensive cancer therapeutics-the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: the John Conley Lecture","volume":"140","author":"Lo","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2008.02.002","article-title":"Resistance against novel anticancer metal compounds: differences and similarities","volume":"11","author":"Berger","year":"2008","journal-title":"Drug Resist Updat"},{"key":"7","first-page":"13","article-title":"Roles of tumor heterogeneity in the development of drug resistance: a call for precision therapy","volume":"42","author":"Wang","year":"2016","journal-title":"Semin Cancer Biol"},{"key":"8","doi-asserted-by":"crossref","first-page":"12368","DOI":"10.3390\/molecules190812368","article-title":"Cyclodepsipeptides: a rich source of biologically active compounds for drug research","volume":"19","author":"Scherkenbeck","year":"2014","journal-title":"Molecules"},{"key":"9","doi-asserted-by":"crossref","first-page":"E239","DOI":"10.1007\/BF02854894","article-title":"Drug discovery from natural sources","volume":"8","author":"Kinghorn","year":"2006","journal-title":"The AAPS Journal"},{"key":"10","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/med.21437","article-title":"The search for potent, small-molecule HDACIs in cancer treatment: a decade after vorinostat","volume":"37","author":"Rescifina","year":"2017","journal-title":"Med Res Rev"},{"key":"11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1021\/tx600259t","article-title":"Enniatin exerts p53-dependent cytostatic and p53-independent cytotoxic activities against human cancer cells","volume":"20","author":"Lemmens-Gruber","year":"2007","journal-title":"Chem Res Toxicol"},{"key":"12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2131\/jts.41.429","article-title":"Beauvericin-induced cell apoptosis through the mitogen-activated protein kinase pathway in human nonsmall cell lung cancer A549 cells","volume":"41","author":"Jow","year":"2016","journal-title":"J Toxicol Sci"},{"key":"13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.toxlet.2014.08.021","article-title":"The mycotoxin beauvericin induces apoptotic cell death in H4IIE hepatoma cells accompanied by an inhibition of NF-kappaB-activity and modulation of MAP-kinases","volume":"231","author":"Proksch","year":"2014","journal-title":"Toxicol Lett"},{"key":"14","first-page":"431","article-title":"Enniatins A1, B and B1 from an endophytic strain of Fusarium tricinctum induce apoptotic cell death in H4IIE hepatoma cells accompanied by inhibition of ERK phosphorylation","volume":"53","author":"Proksch","year":"2008","journal-title":"Molecular Nutrition & Food Research"},{"key":"15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bcp.2014.12.013","article-title":"The naturally born fusariotoxin enniatin B and sorafenib exert synergistic activity against cervical cancerand","volume":"93","author":"Berger","year":"2015","journal-title":"Biochemical Pharmacology"},{"key":"16","first-page":"9","article-title":"The natural fungal metabolite beauvericin exerts anticancer activity: a pre-clinical pilot study","author":"Berger","year":"2017","journal-title":"Toxins (Basel)"},{"key":"17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/00021369.1961.10857803","article-title":"Toxic substances to insects, produced by Aspergillus ochraceus and Oospora destructor","volume":"25","author":"Kodaira","year":"1961","journal-title":"Agric Biol Chem"},{"key":"18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/arch.21160","article-title":"Comparative proteomic analysis of Bombyx mori hemocytes treated with destruxin A","volume":"86","author":"Ye","year":"2014","journal-title":"Arch Insect Biochem Physiol"},{"key":"19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0031-9422(02)00016-X","article-title":"The destruxins: synthesis, biosynthesis, biotransformation, and biological activity","volume":"59","author":"Ward","year":"2002","journal-title":"Phytochemistry"},{"key":"20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bcp.2013.05.022","article-title":"Destruxins: fungal-derived cyclohexadepsipeptides with multifaceted anticancer and antiangiogenic activities","volume":"86","author":"Lemmens-Gruber","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/bbrc.1996.1758","article-title":"Study of structure-activity correlation in destruxins, a class of cyclodepsipeptides possessing suppressive effect on the generation of hepatitis B virus surface antigen in human hepatoma cells","volume":"229","author":"Wu","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-3542(97)01031-0","article-title":"Suppressive effects of destruxin B on hepatitis B virus surface antigen gene expression in human hepatoma cells","volume":"34","author":"Yeh","year":"1997","journal-title":"Antiviral Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/np50118a007","article-title":"The novel desmethyldestruxin B2, from Metarhizium anisopliae, that suppresses hepatitis B virus surface antigen production in human hepatoma cells","volume":"58","author":"Chou","year":"1995","journal-title":"J Nat Prod"},{"key":"24","first-page":"969","article-title":"Inhibition of hepatitis B virus gene expression & replication by crude destruxins from Metarhizium anisopliae var. dcjhyium","volume":"138","author":"Dong","year":"2013","journal-title":"Indian J Med Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ebiom.2016.03.042","article-title":"Targeting the PDGF-B\/PDGFR-beta interface with destruxin A5 to selectively block PDGF-BB\/PDGFR-betabeta signaling and attenuate liver fibrosis","volume":"7","author":"Xu","year":"2016","journal-title":"EBioMedicine"},{"key":"26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S8756-3282(03)00201-1","article-title":"Destruxins, cyclodepsipeptides, block the formation of actin rings and prominent clear zones and ruffled borders in osteoclasts","volume":"33","author":"Woo","year":"2003","journal-title":"Bone"},{"key":"27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000236902","article-title":"Destruxin E decreases Beta-amyloid generation by reducing colocalization of beta-amyloid-cleaving enzyme 1 and beta-amyloid protein precursor","volume":"6","author":"Takinami","year":"2009","journal-title":"Neurodegener Dis"},{"key":"28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1472-6882-14-207","article-title":"Selective apoptotic cell death effects of oral cancer cells treated with destruxin B.","volume":"14","author":"Tzeng","year":"2014","journal-title":"BMC Complement Altern Med"},{"key":"29","first-page":"184","article-title":"Cytotoxicity of cyclodepsipeptides on murine lymphocytes and on L 1210 leukemia cells","volume":"37","author":"Guyot","year":"1983","journal-title":"Biomed Pharmacother"},{"key":"30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0248-4900(92)90037-2","article-title":"effect of fungal cyclodepsipeptides on leukemic cells: study of destruxins A, B, E","volume":"74","author":"Bureau","year":"1992","journal-title":"Biol Cell"},{"key":"31","first-page":"575","article-title":"[Cytometric study of the effects of destruxin E on leukemic cells in mice]. [Article in French]","volume":"305","author":"Bureau","year":"1987","journal-title":"C R Acad Sci III"},{"key":"32","first-page":"1870","article-title":"Apoptotic toxicity of destruxin B in human non-Hodgkin lymphoma cells","volume":"27","author":"Lin","year":"2013","journal-title":"Toxicol"},{"key":"33","first-page":"548929","article-title":"Destruxin B isolated from entomopathogenic fungus metarhizium anisopliae induces apoptosis via a Bcl-2 family-dependent mitochondrial pathway in human nonsmall cell lung cancer cells","volume":"2013","author":"Hsu","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"34","first-page":"552","article-title":"Destruxin B inhibits hepatocellular carcinoma cell growth through modulation of the Wnt\/beta-catenin signaling pathway and epithelial-mesenchymal transition","volume":"28","author":"Yeh","year":"2014","journal-title":"Toxicol"},{"key":"35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.taap.2012.03.007","article-title":"Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging","volume":"261","author":"Tzeng","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"36","first-page":"2735","article-title":"andanticancer effects of destruxin B on human colorectal cancer","volume":"32","author":"Tzeng","year":"2012","journal-title":"Anticancer Res"},{"key":"37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0003-9861(02)00275-8","article-title":"An investigation of the ionophoric characteristics of destruxin A.","volume":"405","author":"Khambay","year":"2002","journal-title":"Arch Biochem Biophys"},{"key":"38","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1248\/bpb.27.587","article-title":"Destruxin E, a cyclodepsipeptide antibiotic, reduces cyclin D1 levels and inhibits anchorage-independent growth of v-Ki-ras-expressed pMAM-ras-REF cells","volume":"27","author":"Tsuchiya","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"39","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1006\/bbrc.1994.2815","article-title":"a specific and readily reversible inhibitor of vacuolar-type H(+)-translocating ATPase","volume":"205","author":"Destruxin","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/cbdv.200490163","article-title":"A new destruxin as inhibitor of vacuolar-type H+-ATPase of Saccharomyces cerevisiae","volume":"2","author":"Hueso-Rodriguez","year":"2005","journal-title":"Chem Biodivers"},{"key":"41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.chroma.2006.03.055","article-title":"Apolar chromatography on Sephadex LH-20 combined with high-speed counter-current chromatography. High yield strategy for structurally closely related analytes-Destruxin derivatives from Metarhizium anisopliae as a case study","volume":"1117","author":"Stuppner","year":"2006","journal-title":"J Chromatogr A"},{"key":"42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0076-6879(86)28066-0","article-title":"Sequential flotation ultracentrifugation","volume":"128","author":"Puppione","year":"1986","journal-title":"Methods Enzymol"},{"key":"43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/1097-0215(20001015)88:2<293::AID-IJC23>3.0.CO;2-S","article-title":"Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs","volume":"88","author":"Micksche","year":"2000","journal-title":"Int J Cancer"},{"key":"44","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Gordon","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"45","doi-asserted-by":"publisher","first-page":"399","DOI":"10.18632\/oncotarget.473","article-title":"Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation","volume":"3","author":"Berger","year":"2012","journal-title":"Oncotarget"},{"key":"46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/bjc.2016.449","article-title":"Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance","volume":"116","author":"Grusch","year":"2017","journal-title":"Br J Cancer"},{"key":"47","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Smyth","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1194\/jlr.M043299","article-title":"Endoplasmic reticulum stress impairs cholesterol efflux and synthesis in hepatic cells","volume":"55","author":"Stangl","year":"2014","journal-title":"J Lipid Res"},{"key":"49","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00216-010-4425-x","article-title":"Metabolite extraction from adherently growing mammalian cells for metabolomics studies: optimization of harvesting and extraction protocols","volume":"399","author":"Oefner","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"50","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1159\/000430211","article-title":"Differential modulation of fast inactivation in cardiac sodium channel splice variants by Fyn tyrosine kinase","volume":"37","author":"Lemmens-Gruber","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1063\/1.1143970","article-title":"Calibration of atomic-force microscope tips","volume":"64","author":"Hutter","year":"1993","journal-title":"Rev Sci Instrum"},{"key":"52","unstructured":"Rosenbluth. Probing the role of single cell mechanics in disease with atomic force microscopy and microfluidics. 2008."},{"key":"53","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacological Reviews"},{"key":"54","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/14728222.2017.1310841","article-title":"The therapeutic potential of targeting ABC transporters to combat multi-drug resistance","volume":"21","author":"Li","year":"2017","journal-title":"Expert Opin Ther Targets"},{"key":"55","first-page":"266","article-title":"[The structure of cellular vaults, their role in the normal cell and in the multidrug resistance of cancer]. [Article in Polish]","volume":"57","author":"Zabel","year":"2011","journal-title":"Postepy Biochem"},{"key":"56","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1016\/S0021-9258(19)57466-X","article-title":"Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins","volume":"261","author":"Gottesman","year":"1986","journal-title":"J Biol Chem"},{"key":"57","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1038\/sj.onc.1206938","article-title":"Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)","volume":"22","author":"Ross","year":"2003","journal-title":"Oncogene"},{"key":"58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3727\/095535491820873335","article-title":"P-glycoprotein content and mediation of vincristine efflux: correlation with the level of differentiation in luminal epithelium of mouse small intestine","volume":"3","author":"Sirotnak","year":"1991","journal-title":"Cancer Commun"},{"key":"59","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00001813-199702000-00005","article-title":"Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60\/ADR cells expressing the multidrug resistance-associated protein MRP","volume":"8","author":"Harding","year":"1997","journal-title":"Anticancer Drugs"},{"key":"60","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Mesirov","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"61","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor","volume":"89","author":"Goldstein","year":"1997","journal-title":"Cell"},{"key":"62","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1042\/BST20150255","article-title":"Current trends in oxysterol research","volume":"44","author":"Wang","year":"2016","journal-title":"Biochem Soc Trans"},{"key":"63","article-title":"Retrospective on cholesterol homeostasis: the central role of SCAP","volume":"87","author":"Goldstein","year":"2017","journal-title":"Annu Rev Biochem"},{"key":"64","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.2174\/092986707781389600","article-title":"Zoledronic acid - a multiplicity of anti-cancer action","volume":"14","author":"Maekawa","year":"2007","journal-title":"Curr Med Chem"},{"key":"65","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature06796","article-title":"Translating molecular discoveries into new therapies for atherosclerosis","volume":"451","author":"Daugherty","year":"2008","journal-title":"Nature"},{"key":"66","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.biotechadv.2011.10.006","article-title":"Development and applications of destruxins: a review","volume":"30","author":"Tzeng","year":"2012","journal-title":"Biotechnol Adv"},{"key":"67","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature10762","article-title":"Clonal evolution in cancer","volume":"481","author":"Maley","year":"2012","journal-title":"Nature"},{"key":"68","doi-asserted-by":"crossref","first-page":"x315","DOI":"10.1093\/annonc\/mdl280","article-title":"Chemoresistance in solid tumours","volume":"17","author":"Johnston","year":"2006","journal-title":"Ann Oncol"},{"key":"69","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1124\/jpet.105.083956","article-title":"Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,2 0,23-tetraazabicyclo [8, 7, 6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines","volume":"314","author":"Chan","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"70","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mnfr.200800384","article-title":"Interactions between ABC-transport proteins and the secondary fusarium metabolites enniatin and beauvericin","volume":"53","author":"Berger","year":"2009","journal-title":"Molecular Nutrition & Food Research"},{"key":"71","doi-asserted-by":"crossref","first-page":"31761","DOI":"10.1074\/jbc.M113.514091","article-title":"P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration","volume":"288","author":"Richardson","year":"2013","journal-title":"J Biol Chem"},{"key":"72","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrc.2016.76","article-title":"The interplay between cell signalling and the mevalonate pathway in cancer","volume":"16","author":"Penn","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"73","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.tem.2017.03.002","article-title":"The role of oxysterols in human cancer","volume":"28","author":"Soucek","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"74","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.cdd.4401530","article-title":"Different apoptotic mechanisms are involved in the antiproliferative effects of 7beta-hydroxysitosterol and 7beta-hydroxycholesterol in human colon cancer cells","volume":"12","author":"Raul","year":"2005","journal-title":"Cell Death Differ"},{"key":"75","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1158\/0008-5472.CAN-15-2613","article-title":"The role of cholesterol in cancer","volume":"76","author":"Robertson","year":"2016","journal-title":"Cancer Res"},{"key":"76","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40169-016-0106-5","article-title":"Mitochondria, cholesterol and cancer cell metabolism","volume":"5","author":"Fernandez-Checa","year":"2016","journal-title":"Clin Transl Med"},{"key":"77","first-page":"167","article-title":"Statins and cancers","volume":"19","author":"Krawczak","year":"2015","journal-title":"Contemp Oncol (Pozn)"},{"key":"78","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1158\/0008-5472.CAN-07-6161","article-title":"Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma","volume":"68","author":"Fernandez-Checa","year":"2008","journal-title":"Cancer Res"},{"key":"79","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12032-015-0717-5","article-title":"Increased lanosterol turnover: a metabolic burden for daunorubicin-resistant leukemia cells","volume":"33","author":"Nordstrom","year":"2016","journal-title":"Med Oncol"},{"key":"80","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1007\/s13277-014-2959-9","article-title":"Establishment and characterization of a bladder cancer cell line with enhanced doxorubicin resistance by mevalonate pathway activation","volume":"36","author":"Hatina","year":"2015","journal-title":"Tumour Biol"},{"key":"81","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.bbrc.2015.01.035","article-title":"Cholesterol reduces the sensitivity to platinum-based chemotherapy via upregulating ABCG2 in lung adenocarcinoma","volume":"457","author":"Wang","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"82","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1038\/bcj.2014.52","article-title":"A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia","volume":"4","author":"Lock","year":"2014","journal-title":"Blood Cancer J"},{"key":"83","doi-asserted-by":"crossref","first-page":"e60975","DOI":"10.1371\/journal.pone.0060975","article-title":"Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells","volume":"8","author":"Massaia","year":"2013","journal-title":"PLoS One"},{"key":"84","doi-asserted-by":"crossref","first-page":"18707","DOI":"10.1074\/jbc.R113.479808","article-title":"Controlling cholesterol synthesis beyond 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR)","volume":"288","author":"Brown","year":"2013","journal-title":"J Biol Chem"},{"key":"85","doi-asserted-by":"crossref","first-page":"26461","DOI":"10.1074\/jbc.271.43.26461","article-title":"Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2","volume":"271","author":"Maeda","year":"1996","journal-title":"J Biol Chem"},{"key":"86","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.biocel.2007.05.002","article-title":"Endoplasmic reticulum stress causes the activation of sterol regulatory element binding protein-2","volume":"39","author":"Austin","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.surfrep.2005.08.003","article-title":"Force measurements with the atomic force microscope: technique, interpretation and applications","volume":"59","author":"Kappl","year":"2005","journal-title":"Surface Science Reports"},{"key":"88","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1038\/srep05005","article-title":"Cholesterol level affects surface charge of lipid membranes in saline solution","volume":"4","author":"Bunker","year":"2014","journal-title":"Sci Rep"},{"key":"89","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.colsurfa.2016.07.040","article-title":"Charge boosting effect of cholesterol on cationic liposomes","volume":"506","author":"Konno","year":"2016","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"90","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/ijc.2910420517","article-title":"Plasma membrane lipid composition of vinblastine sensitive and resistant human leukaemic lymphoblasts","volume":"42","author":"Mountford","year":"1988","journal-title":"Int J Cancer"},{"key":"91","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0163-7827(01)00020-0","article-title":"Cholesterol interactions with phospholipids in membranes","volume":"41","author":"Slotte","year":"2002","journal-title":"Prog Lipid Res"},{"key":"92","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.chemphyslip.2016.03.001","article-title":"Cholesterol oxidation products and their biological importance","volume":"199","author":"Vattulainen","year":"2016","journal-title":"Chem Phys Lipids"},{"key":"93","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1039\/C7NR03926C","article-title":"Lipid nanodomains change ion channel function","volume":"9","author":"Bezrukov","year":"2017","journal-title":"Nanoscale"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T21:46:39Z","timestamp":1720302399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":93,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2018,5,22]]}},"alternative-id":["25432","29876015"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.25432","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]}}}